SCHEMBL7654419

SCHEMBL7654419

COc1ccc(-c2cc(O)cc(=O)o2)cc1OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 5/20 0.61
FYN P06241 1/20 0.59
PDE4A P27815 2/20 0.57
TERT O14746 1/20 0.54
ALDH1A1 P00352 5/20 0.54
MAPK1 P28482 4/20 0.54
KDM4E B2RXH2 3/20 0.54
HSD17B10 Q99714 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
NPC1 O15118 1/20 0.54
RAB9A P51151 1/20 0.54
MAPT P10636 4/20 0.53
CYP1A1 P04798 4/20 0.53
CYP1A2 P05177 4/20 0.53
CYP3A4 P08684 3/20 0.53
OPRD1 P41143 1/20 0.53
USP2 O75604 1/20 0.53
LMNA P02545 1/20 0.53
ELANE P08246 1/20 0.53
MEN1 O00255 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6827893 0.81 PDE4A (0.57) CYP1B1FYNPDE4ATERTALDH1A1
SCHEMBL6829505 0.81 EGFR (0.62) CYP1B1ALDH1A1MAPK1KDM4EHSD17B10
SCHEMBL6827686 0.79 ALDH1A1 (0.57) CYP1B1FYNPDE4ATERTALDH1A1
SCHEMBL3125629 0.78 PDE4A (0.72) CYP1B1FYNPDE4ATERTALDH1A1
SCHEMBL2485835 0.77 CYP1B1 (0.83) CYP1B1FYNALDH1A1MAPK1KDM4E
SCHEMBL6827354 0.77 CYP3A4 (0.60) CYP1B1ALDH1A1MAPK1KDM4EHSD17B10
SCHEMBL30365934 0.76 CYP1B1 (1.00) CYP1B1FYNALDH1A1MAPK1KDM4E
SCHEMBL2483636 0.76 CYP1B1 (1.00) CYP1B1FYNALDH1A1MAPK1KDM4E
SCHEMBL29883103 0.76 CYP1B1 (1.00) CYP1B1FYNALDH1A1MAPK1KDM4E
SCHEMBL6827384 0.76 ALDH1A1 (0.60) CYP1B1ALDH1A1KDM4EHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6384045-B1 TREATMENT OF ALZHEIMER'S DISEASE AND ANTICANCER AGENTS KANSAS STATE UNIVERSITY RESEARCH FOUNDATION 2002-05-07 US disclosed
US-5958970-A ENZYME INHIBITORS OF ACETYLCHOLINESTERASE (ACHE) AND ACYL-COA:CHOLESTEROL ACYLTRANSFERASE (ACAT); USED IN THE TREATMENT OF ALZHEIMER'S DISEASE, ATHEROSCLEROSIS AND HYPERCHOLESTEROLEMIA KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 1999-09-28 US disclosed